HOME >> BIOLOGY >> NEWS
Sequence matters when using novel agent

TORONTO - An experimental agent that targets a cancer cell's protein shredding machinery (the proteasome) should be given either before or with taxane-based chemotherapy drugs, but not after, say researchers at The University of Texas M. D. Anderson Cancer Center who conducted laboratory tests using prostate cancer cells.

The finding is important because the new therapy, known as PS-341 (Velcade), will likely be tried as new treatment for a number of cancers due to its effectiveness in multiple myeloma, says Christos Papandreou, M.D., Ph.D., assistant professor in the department of Genitourinary Medical Oncology.

"It appears PS-341 could become quite a hit as a novel proteasome inhibitor, a drug that increases the effectiveness of chemotherapy agents," Papandreou says. "We know that while the sequence it is used in doesn't matter with certain classes of chemotherapy drugs, it does with others. Hopefully, future clinical trials will reflect this new understanding."

The findings were published in the Proceedings for the 2003 Annual Meeting of the American Association for Cancer Research.

Last summer, the agent demonstrated a dramatic success when used to treat patients with multiple myeloma. Researchers at Dana-Farber Cancer Institute, where it was tested, said 70 percent of 78 patients with advanced multiple myeloma improved - an unheard of benefit in that disease. The agent is now being used in a Phase II clinical trial in advanced prostate cancer, and several Phase I clinical trials are underway, or have been completed, testing PS-341 in pancreatic, lung and colorectal cancers.

The drug is designed to specifically inhibit proteasomes, the cell's enzymatic protein-shredding machinery, responsible for breaking down a variety of proteins, including many that regulate cell division.

M. D. Anderson researchers designed experiments in which they treated prostate cancer cells with PS-341 alone or in combination with
'"/>

Contact: Laura Sussman
lsussman@mdanderson.org
713-792-0655
University of Texas M. D. Anderson Cancer Center
9-Apr-2003


Page: 1 2

Related biology news :

1. Sequence of human chromosome 7 is fine-tuned and finished
2. Sequenced malaria genome exposes novel drug targets
3. Sequence provides insights into a pathogens virulence mechanism allowing for vaccine development
4. New Science Press launches Proteins: From Sequence to Structure
5. Sequencers take a bird in hand
6. Genetic Stowaways May Contribute To Evolutionary Change: Adjacent Sequences Tag Along With Mobile DNA Elements, Study Shows
7. Scientists Sequence Chlamydia Trachomatis Genome
8. New Insights On Sequence of Cell Death After Brain Injury: Understanding Cellular Events After Brain Trauma Could Lead To Better Therapies
9. Syphilis Genome Sequence Offers Clues To Better Diagnosis, Prevention And Treatment
10. Why some animals have smaller eyes: Lifestyle matters
11. Why genetic diversity matters

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/13/2018)... CITY, N.J. (PRWEB) , ... December 12, 2018 ... ... the research and advancement of regenerative cellular therapy, has announced the launch of ... new technique to a gold standard approach of aspirating a patients autologous bone ...
(Date:12/13/2018)... FRANCISCO (PRWEB) , ... December 13, 2018 , ... ... sciences, just released a must-see documentary entitled “What Researchers Need to Know ... Reproducibility Issues in Life Science Research series. The goal of this film is ...
(Date:12/6/2018)... ... December 06, 2018 , ... ... instruments, consumables and laboratory contract services, throughout his career. During his recent five-year ... US Sales team and established the commercial laboratory operations in Brunswick, Maine. Through ...
Breaking Biology News(10 mins):
(Date:1/8/2019)... ... 2019 , ... The American Society of Gene and Cell Therapy’s ... committee made up of industry leaders identified by the ASGCT board of directors. In ... created to support ASGCT members designing transformative pilot studies in gene and cell therapy ...
(Date:1/4/2019)... (PRWEB) , ... January 02, 2019 , ... ... technology to detect precancer and cancer cells in blood, has been named as ... , a global biotech company developing cell therapies for cancer treatment, will use ...
(Date:12/19/2018)... FREDERICK, Md. (PRWEB) , ... December 19, 2018 ... ... solutions for Life Science, announces the validated release of Limfinity® version 7.1. The ... another important technical offering from RURO as 2018 comes to an end. , ...
(Date:12/14/2018)... EDMONTON, Alberta (PRWEB) , ... December 14, 2018 ... ... the Eye Machine Canada Inc., have been given the green light to immediately ... Age-Related Macular Degeneration (AMD). , The medical devices bureau of Health Canada has ...
Breaking Biology Technology:
Cached News: